gastroplustm v9.8 (Simulations Plus Inc)
90
Structured Review
Simulations Plus Inc
gastroplustm v9.8
Gastroplustm V9.8, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+v9%2E8/gastroplustm+software/pm39961585-43-0-2
Average 90 stars, based on 1 article reviews
Gastroplustm V9.8, supplied by Simulations Plus Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gastroplustm+v9%2E8/gastroplustm+software/pm39961585-43-0-2
Average 90 stars, based on 1 article reviews
gastroplustm v9.8 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages. Article Snippet: Funding information Joint Funds for the Innovation of Science and Technology, Fujian Province, China (Grant number: 2023Y9025); Natural Science Foundation of Fujian Province, China (Grant number: 2021 J01701); Young and Middleaged Backbone Personnel Training Project of Fujian Province Health and Family Planning Commission, China (Grant number: 2023GGA027); Young and Middle-aged Teachers Education Research Project of Fujian Province, China (Grant number: JAT210110).. Aims: Oxcarbazepine (OXC) has been approved as monotherapy or adjunctive therapy for paediatric partial seizures.. There are few reports on the pharmacokinetics (PK) of OXC in paediatric patients with renal impairment (RI), especially dosage studies of RI, which are rarely conducted on paediatric patients. |